Novozymes A/S
CSE:NZYM B

Watchlist Manager

Novozymes A/S

CSE:NZYM B

Watchlist

Dividends

Price: 403 DKK -3.93% Market Closed

Market Cap: 165.6B DKK

Have any thoughts about
Novozymes A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Fubotv Inc NYSE:FUBO	Media
US	Bank of America Corp NYSE:BAC	Banking
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Uber Technologies Inc NYSE:UBER	Road & Rail
CN	NIO Inc NYSE:NIO	Automobiles
US	Fluor Corp NYSE:FLR	Construction
US	Jacobs Engineering Group Inc NYSE:J	Professional Services
US	TopBuild Corp NYSE:BLD	Consumer products
US	Abbott Laboratories NYSE:ABT	Health Care
US	Chevron Corp NYSE:CVX	Energy
US	Occidental Petroleum Corp NYSE:OXY	Energy
US	Matrix Service Co NASDAQ:MTRX	Construction
US	Automatic Data Processing Inc NASDAQ:ADP	Technology
US	Qualcomm Inc NASDAQ:QCOM	Semiconductors
US	PayPal Holdings Inc NASDAQ:PYPL	Technology
US	Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 403 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NZYM B Alert

Novozymes A/S

403

-16.5 (-3.93%)

52 Week Range	316.4 419.5
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	PayPal Holdings Inc NASDAQ:PYPL	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Novozymes A/S

What unique competitive advantages
does Novozymes A/S hold over its rivals?

What risks and challenges
does Novozymes A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Novozymes A/S.

What unique competitive advantages
does Novozymes A/S hold over its rivals?

What risks and challenges
does Novozymes A/S face in the near future?

Summarize the latest earnings call
of Novozymes A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novozymes A/S.

Provide P/S
for Novozymes A/S.

Provide P/E
for Novozymes A/S.

Provide P/OCF
for Novozymes A/S.

Provide P/FCFE
for Novozymes A/S.

Provide P/B
for Novozymes A/S.

Provide EV/S
for Novozymes A/S.

Provide EV/GP
for Novozymes A/S.

Provide EV/EBITDA
for Novozymes A/S.

Provide EV/EBIT
for Novozymes A/S.

Provide EV/OCF
for Novozymes A/S.

Provide EV/FCFF
for Novozymes A/S.

Provide EV/IC
for Novozymes A/S.

Show me price targets
for Novozymes A/S made by professional analysts.

What are the Revenue projections
for Novozymes A/S?

How accurate were the past Revenue estimates
for Novozymes A/S?

What are the Net Income projections
for Novozymes A/S?

How accurate were the past Net Income estimates
for Novozymes A/S?

What are the EPS projections
for Novozymes A/S?

How accurate were the past EPS estimates
for Novozymes A/S?

What are the EBIT projections
for Novozymes A/S?

How accurate were the past EBIT estimates
for Novozymes A/S?

Compare the revenue forecasts
for Novozymes A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novozymes A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novozymes A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novozymes A/S compared to its peers.

Compare the P/E ratios
of Novozymes A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Novozymes A/S with its peers.

Analyze the financial leverage
of Novozymes A/S compared to its main competitors.

Show all profitability ratios
for Novozymes A/S.

Provide ROE
for Novozymes A/S.

Provide ROA
for Novozymes A/S.

Provide ROIC
for Novozymes A/S.

Provide ROCE
for Novozymes A/S.

Provide Gross Margin
for Novozymes A/S.

Provide Operating Margin
for Novozymes A/S.

Provide Net Margin
for Novozymes A/S.

Provide FCF Margin
for Novozymes A/S.

Show all solvency ratios
for Novozymes A/S.

Provide D/E Ratio
for Novozymes A/S.

Provide D/A Ratio
for Novozymes A/S.

Provide Interest Coverage Ratio
for Novozymes A/S.

Provide Altman Z-Score Ratio
for Novozymes A/S.

Provide Quick Ratio
for Novozymes A/S.

Provide Current Ratio
for Novozymes A/S.

Provide Cash Ratio
for Novozymes A/S.

What is the historical Revenue growth
over the last 5 years for Novozymes A/S?

What is the historical Net Income growth
over the last 5 years for Novozymes A/S?

What is the current Free Cash Flow
of Novozymes A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novozymes A/S.

P/E
Price to Earnings

54.8

Current

54.3

Median

21.7

Industry

Higher than median

Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E

54.8

Market Cap

165.6B DKK

Net Income

3B DKK

All Countries

Forward Multiples

			Market Cap	P/E
DK		Novozymes A/S CSE:NZYM B	165.6B DKK	54.8
US		Sherwin-Williams Co NYSE:SHW	90.4B USD	35.3
JP		Shin-Etsu Chemical Co Ltd TSE:4063	11.4T JPY	22.2
US		Ecolab Inc NYSE:ECL	70.2B USD	41
CH		Givaudan SA SIX:GIVN	37.8B CHF	36.6
US		Dupont De Nemours Inc NYSE:DD	34.6B USD	52.2
IN		Asian Paints Ltd NSE:ASIANPAINT	2.8T INR	55.4
CN		Wanhua Chemical Group Co Ltd SSE:600309	237.2B CNY	14.4
CH	D	DSM-Firmenich AG AEX:DSFIR	29B EUR	13.6
US		PPG Industries Inc NYSE:PPG	28.9B USD	19.4
US		International Flavors & Fragrances Inc NYSE:IFF	25.4B USD	-10.8

				Earnings Growth
DK		Novozymes A/S CSE:NZYM B	Average P/E: 34.5 54.8	N/A
US		Sherwin-Williams Co NYSE:SHW	35.3	53%
JP		Shin-Etsu Chemical Co Ltd TSE:4063	22.2	42%
US		Ecolab Inc NYSE:ECL	41	77%
CH		Givaudan SA SIX:GIVN	36.6	44%
US		Dupont De Nemours Inc NYSE:DD	52.2	395%
IN		Asian Paints Ltd NSE:ASIANPAINT	55.4	15%
CN		Wanhua Chemical Group Co Ltd SSE:600309	14.4	48%
CH	D	DSM-Firmenich AG AEX:DSFIR	13.6	-44%
US		PPG Industries Inc NYSE:PPG	19.4	84%
US		International Flavors & Fragrances Inc NYSE:IFF	Negative Multiple: -10.8	N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

P/E

317.7

2-Years Forward

P/E

289

3-Years Forward

P/E

N/A

Novozymes A/S
CSE:NZYM B

P/E
Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Novozymes A/S CSE:NZYM B

P/E Price to Earnings

P/E Forward Multiples

See Also

Company

Help

Tools

Stocks

Novozymes A/S
CSE:NZYM B

P/E
Price to Earnings